On the stock market since 1998, it operates in the world of health and science. It has 102 employees. Now — the numbers.
This is an established company with proven profits.
No real growth (-2% a year). Red columns mark years that ended in a loss.
If every debt were paid off today, $1.3M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
R&D Investment: Spending on future research is low.
An investor who bought at the very peak is down 85% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The net profit margin is 63% — still a thick cushion, though costs have been eating into it lately.
There is $2.5M in the vault; even if every debt were paid off, $1.3M would remain.
The share set aside for the future is small; the pace of new ideas may slow. Council score: 2/10.
On our five-subject report card, IDXG sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: IDXG is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.